Plant Biotech Co. Phyton Buys Chemotherapy Patents

Law360, New York (October 12, 2009, 7:59 PM EDT) -- Positioning itself to become a leading provider of certain common chemotherapy agents, plant culture technology company Phyton Biotech LLC announced Monday that it had purchased the intellectual property and other assets of Natural Pharmaceuticals Inc., a major manufacturer of cancer treatment ingredients derived from yew trees.

Phyton — an affiliate of German firm Phyton Biotech GmbH and DFB Pharmaceuticals Inc. — and Beverley, Mass.-based Natural Pharmaceuticals declined to disclose the financial terms of the deal.

The companies are privately held, and no details were filed with...
To view the full article, register now.